- Home
- USLM vs VRNA Comparison
USLM vs VRNA Comparison
Compare USLM & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- VRNA
- Stock Information
- Founded
- USLM 1948
- VRNA 2005
- Country
- USLM United States
- VRNA United Kingdom
- Employees
- USLM N/A
- VRNA N/A
- Industry
- USLM Other Metals and Minerals
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- VRNA Health Care
- Exchange
- USLM Nasdaq
- VRNA Nasdaq
- Market Cap
- USLM 3.2B
- VRNA 3.4B
- IPO Year
- USLM N/A
- VRNA 2017
- Fundamental
- Price
- USLM $95.19
- VRNA $67.96
- Analyst Decision
- USLM
- VRNA Strong Buy
- Analyst Count
- USLM 0
- VRNA 7
- Target Price
- USLM N/A
- VRNA $57.14
- AVG Volume (30 Days)
- USLM 142.7K
- VRNA 1.3M
- Earning Date
- USLM 02-03-2025
- VRNA 02-27-2025
- Dividend Yield
- USLM 0.25%
- VRNA N/A
- EPS Growth
- USLM 45.10
- VRNA N/A
- EPS
- USLM 3.79
- VRNA N/A
- Revenue
- USLM $317,721,000.00
- VRNA $5,624,000.00
- Revenue This Year
- USLM N/A
- VRNA N/A
- Revenue Next Year
- USLM N/A
- VRNA $571.44
- P/E Ratio
- USLM $26.69
- VRNA N/A
- Revenue Growth
- USLM 12.94
- VRNA 1127.95
- 52 Week Low
- USLM $49.99
- VRNA $11.39
- 52 Week High
- USLM $159.53
- VRNA $68.64
- Technical
- Relative Strength Index (RSI)
- USLM 22.99
- VRNA 76.88
- Support Level
- USLM $99.24
- VRNA $62.24
- Resistance Level
- USLM $106.93
- VRNA $65.50
- Average True Range (ATR)
- USLM 4.60
- VRNA 2.78
- MACD
- USLM -0.30
- VRNA 0.22
- Stochastic Oscillator
- USLM 2.22
- VRNA 94.86
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime, and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.